Kilgas S, Syed A, Toolan-Kerr P, Swift M, Roychoudhury S, Sarkar A
Nat Commun. 2024; 15(1):8438.
PMID: 39349456
PMC: 11443056.
DOI: 10.1038/s41467-024-52862-w.
Davis W, Drummond C, Diermeier S, Reid G
Genes (Basel). 2024; 15(7).
PMID: 39062685
PMC: 11276205.
DOI: 10.3390/genes15070906.
Asadi-Tarani M, Darashti A, Javadi M, Rezaei M, Saravani M, Salimi S
Mol Biol Rep. 2024; 51(1):486.
PMID: 38578390
DOI: 10.1007/s11033-024-09420-w.
Le L, Nhu C
Int J Mol Sci. 2023; 24(18).
PMID: 37762106
PMC: 10531487.
DOI: 10.3390/ijms241813805.
Sanchez A, Lhuillier J, Grosjean G, Ayadi L, Maenner S
Cancers (Basel). 2023; 15(16).
PMID: 37627188
PMC: 10453084.
DOI: 10.3390/cancers15164160.
Cell Cycle-Related lncRNAs as Innovative Targets to Advance Cancer Management.
Liang X, Liu Y, Chen F, Zhou Z, Zhang L, Lin Z
Cancer Manag Res. 2023; 15:547-561.
PMID: 37426392
PMC: 10327678.
DOI: 10.2147/CMAR.S407371.
Geometric complement heterogeneous information and random forest for predicting lncRNA-disease associations.
Yao D, Zhang T, Zhan X, Zhang S, Zhan X, Zhang C
Front Genet. 2022; 13:995532.
PMID: 36092871
PMC: 9448985.
DOI: 10.3389/fgene.2022.995532.
ANRIL regulates multiple molecules of pathogenetic significance in diabetic nephropathy.
Sooshtari P, Feng B, Biswas S, Levy M, Lin H, Su Z
PLoS One. 2022; 17(8):e0270287.
PMID: 35984863
PMC: 9390929.
DOI: 10.1371/journal.pone.0270287.
The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis.
Lin K, Baritaki S, Vivarelli S, Falzone L, Scalisi A, Libra M
Antioxidants (Basel). 2022; 11(6).
PMID: 35740092
PMC: 9227079.
DOI: 10.3390/antiox11061195.
An Unanticipated Modulation of Cyclin-Dependent Kinase Inhibitors: The Role of Long Non-Coding RNAs.
Bencivenga D, Stampone E, Vastante A, Barahmeh M, Della Ragione F, Borriello A
Cells. 2022; 11(8).
PMID: 35456025
PMC: 9028986.
DOI: 10.3390/cells11081346.
Dynamical Analysis of a Boolean Network Model of the Oncogene Role of lncRNA ANRIL and lncRNA UFC1 in Non-Small Cell Lung Cancer.
Gupta S, Hashimoto R
Biomolecules. 2022; 12(3).
PMID: 35327612
PMC: 8946683.
DOI: 10.3390/biom12030420.
Crosstalk between Long Non Coding RNAs, microRNAs and DNA Damage Repair in Prostate Cancer: New Therapeutic Opportunities?.
Orafidiya F, Deng L, Bevan C, Fletcher C
Cancers (Basel). 2022; 14(3).
PMID: 35159022
PMC: 8834032.
DOI: 10.3390/cancers14030755.
Long non-coding RNAs regulating multiple proliferative pathways in cancer cell.
De Martino M, Esposito F, Pallante P
Transl Cancer Res. 2022; 10(6):3140-3157.
PMID: 35116622
PMC: 8797882.
DOI: 10.21037/tcr-21-230.
Long Non-Coding RNA as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma.
Lee A, Ferdjallah A, Moore E, Kim D, Nath A, Greengard E
Int J Mol Sci. 2021; 22(20).
PMID: 34681828
PMC: 8538287.
DOI: 10.3390/ijms222011168.
BiGAN: LncRNA-disease association prediction based on bidirectional generative adversarial network.
Yang Q, Li X
BMC Bioinformatics. 2021; 22(1):357.
PMID: 34193046
PMC: 8247109.
DOI: 10.1186/s12859-021-04273-7.
HOTAIR beyond repression: In protein degradation, inflammation, DNA damage response, and cell signaling.
Price R, Bhan A, Mandal S
DNA Repair (Amst). 2021; 105:103141.
PMID: 34183273
PMC: 10426209.
DOI: 10.1016/j.dnarep.2021.103141.
Long non-coding RNA exploration for mesenchymal stem cell characterisation.
Riquier S, Mathieu M, Bessiere C, Boureux A, Ruffle F, Lemaitre J
BMC Genomics. 2021; 22(1):412.
PMID: 34088266
PMC: 8178833.
DOI: 10.1186/s12864-020-07289-0.
A novel E2F1-regulated lncRNA, LAPAS1, is required for S phase progression and cell proliferation.
Baruch E, Nizri-Megnaji T, Berkowitz O, Ginsberg D
Oncotarget. 2021; 12(11):1072-1082.
PMID: 34084281
PMC: 8169067.
DOI: 10.18632/oncotarget.27962.
Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival.
Kattan S, Hobani Y, Shaheen S, Mokhtar S, Hussein M, Toraih E
Cell Mol Biol Lett. 2021; 26(1):14.
PMID: 33849428
PMC: 8045214.
DOI: 10.1186/s11658-021-00258-9.
Non-coding RNAs and potential therapeutic targeting in cancer.
Toden S, Zumwalt T, Goel A
Biochim Biophys Acta Rev Cancer. 2020; 1875(1):188491.
PMID: 33316377
PMC: 7856203.
DOI: 10.1016/j.bbcan.2020.188491.